TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19691748

Group type: EXPERIMENTAL
Intervention: 5% topical minoxidil
Number of subjects: 300

Group type: COMPARATOR
Intervention: 1% topical minoxidil
Number of subjects: 300
Study: 17301299

Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine
Number of subjects: 8352

Group type: COMPARATOR
Intervention: Inactivated vaccine
Number of subjects: 8352
Study: 14752074

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention (n = 118)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Conventional care (n = 119)
Number of subjects: 237
Study: 11693063

Group type: EXPERIMENTAL
Intervention: Idarubicine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mitoxantrone
Number of subjects: 60
Study: 7939401

Group type: EXPERIMENTAL
Intervention: Colonoscopy follow-up for polyps < 10 mm
Number of subjects: 116
Study: 2905709

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 29437307

Group type: EXPERIMENTAL
Intervention: Face-to-face instruction with no audiovisual support
Number of subjects: 2225

Group type: EXPERIMENTAL
Intervention: Face-to-face instruction with audiovisual support
Number of subjects: 2225

Group type: EXPERIMENTAL
Intervention: Audiovisual instruction without face-to-face instruction
Number of subjects: 2225

Group type: EXPERIMENTAL
Intervention: Audiovisual instruction with face-to-face instruction
Number of subjects: 2225

Group type: COMPARATOR
Intervention: Control group (no instruction)
Number of subjects: 2225
Study: 27908464

Group type: EXPERIMENTAL
Intervention: 6 weeks of exercise rehabilitation
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 12 weeks of exercise rehabilitation
Number of subjects: 42
Study: 29378102

Group type: EXPERIMENTAL
Intervention: Standard diet plus two jelly drinks a day for 2 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard diet (Control group)
Number of subjects: 50
Study: 24163238

Group type: EXPERIMENTAL
Intervention: Mobile phone text-messaging intervention for 12 weeks
Number of subjects: 179

Group type: COMPARATOR
Intervention: Self-help pamphlet about smoking cessation
Number of subjects: 179
Study: 20538982

Group type: EXPERIMENTAL
Intervention: Umbilical cord serum
Number of subjects: 32

Group type: COMPARATOR
Intervention: Autologous serum
Number of subjects: 32

Group type: COMPARATOR
Intervention: Artificial tears (0.5% HPMC+0.3% glycerin)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 32
Study: 18215977

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) plus stavudine and lamivudine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Switching from stavudine to tenofovir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) therapy
Number of subjects: 0
Study: 16704091

Group type: EXPERIMENTAL
Intervention: Straight wire appliance
Number of subjects: 80

Group type: COMPARATOR
Intervention: Edgewise appliance
Number of subjects: 80
Study: 14669176

Group type: EXPERIMENTAL
Intervention: Generic total contact seat
Number of subjects: 207

Group type: COMPARATOR
Intervention: Low air loss bed
Number of subjects: 207

Group type: COMPARATOR
Intervention: Upgraded bed overlay
Number of subjects: 207
Study: 10892659

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg/day for 3 days)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Coadministration of Ang II (0.3 ng/min)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Losartan pretreatment with Ang II
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no losartan)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 9
Study: 8814373

Group type: EXPERIMENTAL
Intervention: Granisetron (single intravenous dose)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Ondansetron (twice-daily oral for 3 or 4 days)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 26

Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 26
Study: 1300214

Group type: EXPERIMENTAL
Intervention: Analysis of covariance (ANCOVA) for baseline correction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simple pre‐post difference scores and percentage change scores
Number of subjects: 0
Study: 3918652

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 31003626

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil (n=2543)
Number of subjects: 7447

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with nuts (n=2454)
Number of subjects: 7447

Group type: COMPARATOR
Intervention: Control diet (advice to reduce dietary fat; n=2450)
Number of subjects: 7447
Study: 29372023

Group type: EXPERIMENTAL
Intervention: Therapeutic lumbar facet joint nerve blocks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost of therapeutic lumbar facet joint nerve blocks
Number of subjects: 0
Study: 26784272

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (35,000 IU/week)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 24681179

Group type: EXPERIMENTAL
Intervention: 40 mg parecoxib injection 30‐45 min before anesthesia induction and 4 ml saline injection when gallbladder was removed
Number of subjects: 120

Group type: COMPARATOR
Intervention: 4 ml saline injection 30‐45 min before anesthesia induction and 40 mg parecoxib injection when gallbladder was removed
Number of subjects: 120

Group type: COMPARATOR
Intervention: 4 ml saline injection 30‐45 min before anesthesia induction and the time when gallbladder was removed
Number of subjects: 120
Study: 22063735

Group type: EXPERIMENTAL
Intervention: Prednisolone treatment within the first week after onset of symptoms
Number of subjects: 2

Group type: COMPARATOR
Intervention: No medication (control group)
Number of subjects: 2
Study: 19348542

Group type: EXPERIMENTAL
Intervention: Blushing
Number of subjects: 128

Group type: COMPARATOR
Intervention: Neutral expression without blushing
Number of subjects: 128
Study: 17636090

Group type: EXPERIMENTAL
Intervention: Ecopipam 100 mg daily for 12 weeks
Number of subjects: 1667

Group type: EXPERIMENTAL
Intervention: Ecopipam 100 mg daily for 52 weeks
Number of subjects: 1667

Group type: COMPARATOR
Intervention: Ecopipam vs. placebo
Number of subjects: 1667

Group type: EXPERIMENTAL
Intervention: Ecopipam
Number of subjects: 1667
Study: 15691239

Group type: EXPERIMENTAL
Intervention: Inhaled hypertonic saline (4.5% for ≤ 15 min without bronchodilator pretreatment)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Inhaled methacholine (maximum cumulative dose 4 micromol)
Number of subjects: 56
Study: 12674492

Group type: EXPERIMENTAL
Intervention: Preventive home visits in intervention communities
Number of subjects: 4059

Group type: COMPARATOR
Intervention: Control communities (no intervention)
Number of subjects: 4059
Study: 10037073

Group type: EXPERIMENTAL
Intervention: G-CSF (100 to 250 microg) given daily until neutrophil counts rose to greater than 1000/microL
Number of subjects: 24

Group type: COMPARATOR
Intervention: Untreated group receiving antibiotic therapy only
Number of subjects: 24
Study: 7793470

Group type: EXPERIMENTAL
Intervention: ECT with right unilateral electrode placement and low intensity stimulus
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: ECT with right unilateral electrode placement and high intensity stimulus
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: ECT with bilateral electrode placement and low intensity stimulus
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: ECT with bilateral electrode placement and high intensity stimulus
Number of subjects: 71
Study: 2033693

Group type: EXPERIMENTAL
Intervention: Thromboembolic stockings
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: External sequential pneumatic compression stockings
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Heparin plus dihydroergotamine
Number of subjects: 74
Study: 6763394

Group type: EXPERIMENTAL
Intervention: Standard dose tobramycin
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Low dose tobramycin
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Standard dose amikacin
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Low dose amikacin
Number of subjects: 29
Study: 30460609

Group type: EXPERIMENTAL
Intervention: Vitamin D3 20,000 IU/week for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 29208620

Group type: EXPERIMENTAL
Intervention: Clinical decision support tool
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive access to institutional guidelines
Number of subjects: 0
Study: 26322834

Group type: EXPERIMENTAL
Intervention: Microaneurysm activity using the RetmarkerDR
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Microaneurysm turnover
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: ETDRS severity level assessment
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Spectral-domain optical coherence tomography (SD-OCT)
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: Retinal thickness assessment
Number of subjects: 374
Study: 25715720

Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion (RME) using Haas expander
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (untreated individuals)
Number of subjects: 30
Study: 22772870

Group type: EXPERIMENTAL
Intervention: S-pantoprazole 20 mg
Number of subjects: 129

Group type: COMPARATOR
Intervention: pantoprazole 40 mg
Number of subjects: 129
Study: 19773005

Group type: EXPERIMENTAL
Intervention: School-based West Nile virus health education program
Number of subjects: 345
Study: 17323787

Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg (pretreatment)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg (concomitant treatment)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Aspirin (both treatments)
Number of subjects: 148
Study: 15712732

Group type: EXPERIMENTAL
Intervention: Lomb-Scargle periodogram (LSP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fast Fourier Transform (FFT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sleep stage segmentation
Number of subjects: 0
Study: 11424301

Group type: EXPERIMENTAL
Intervention: Standard random effects model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified test
Number of subjects: 0
Study: 9844097

Group type: EXPERIMENTAL
Intervention: Vertical jumping exercise (50 jumps, 6 days/week, mean height 8.5 cm)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Vertical jumping exercise (50 jumps, 6 days/week)
Number of subjects: 123
Study: 7857732

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study: 2754630

Group type: EXPERIMENTAL
Intervention: Nortriptyline treatment for seven weeks with plasma levels kept between 50‐180 ng/ml
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Nortriptyline treatment
Number of subjects: 31
Study: 865738

Group type: EXPERIMENTAL
Intervention: Analgesia
Number of subjects: 115

Group type: COMPARATOR
Intervention: General inhalation anesthesia
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Analgesia and General inhalation anesthesia
Number of subjects: 115
Study: 31125086

Group type: EXPERIMENTAL
Intervention: Diverse window views and different daylight exposure in 46 different patient rooms
Number of subjects: 296
Study: 27416930

Group type: EXPERIMENTAL
Intervention: Higher proportion of photos of mothers interacting with their babies
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lower proportion of posts of baby smiling photos
Number of subjects: 20
Study: 25755148

Group type: EXPERIMENTAL
Intervention: Community-based walking exercise program with training, monitoring and coaching (TMC) components over 14 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard advice to walk (control group)
Number of subjects: 25
Study: 23815562

Group type: EXPERIMENTAL
Intervention: Olmesartan/Amlodipine combination (20/5 mg)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Olmesartan (20 mg)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Amlodipine (10 mg)
Number of subjects: 276
Study: 21883159

Group type: EXPERIMENTAL
Intervention: Secure attachment with moderately irritable infants
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Secure attachment with highly irritable infants
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Insecure attachment with moderately irritable infants
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Insecure attachment with highly irritable infants
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Highly irritable and insecurely attached toddlers
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Moderately irritable and insecurely attached toddlers
Number of subjects: 84
Study: 19218075

Group type: EXPERIMENTAL
Intervention: Soft tissue release (STR)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 20
Study: 17374567

Group type: EXPERIMENTAL
Intervention: Tailored individualized feedback based on the Transtheoretical Model of Behavior Change using a computer‐based multimedia program
Number of subjects: 0

Group type: COMPARATOR
Intervention: General information on contraception
Number of subjects: 0
Study: 12718225

Group type: EXPERIMENTAL
Intervention: Trimethazidine (20 mg thrice a day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard basic therapy
Number of subjects: 20
Study: 11206600

Group type: COMPARATOR
Intervention: sertraline, 50 mg/day
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: sertraline, 100 mg/day
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: fluoxetine, 20 mg/day
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: sertraline, 100 mg/day (after dose increase)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: sertraline, 200 mg/day (after dose increase)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: fluoxetine, 40 mg/day (after dose increase)
Number of subjects: 44
Study: 9313279

Group type: EXPERIMENTAL
Intervention: Placebo cream with suggestion that it might help reduce needle pain
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Placebo cream with no indication of purpose
Number of subjects: 117

Group type: COMPARATOR
Intervention: No cream (control group)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Observer ratings for cream plus suggestion
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Observer ratings for cream alone
Number of subjects: 117
Study: 8384050

Group type: EXPERIMENTAL
Intervention: Fibrin adhesive applied to the raw surface of liver resections for 20 patients
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (nothing applied) for 20 patients
Number of subjects: 40
Study: 3512971

Group type: EXPERIMENTAL
Intervention: cisplatin + 4'epi‐adriamycin + cyclophosphamide (PEC)
Number of subjects: 51

Group type: COMPARATOR
Intervention: cisplatin + adriamycin + cyclophosphamide (PAC)
Number of subjects: 51
Study: 30081275

Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone
Number of subjects: 2800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2800
Study: 27168572

Group type: EXPERIMENTAL
Intervention: Telehealth coaching promoting nutrition and exercise
Number of subjects: 234

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 234
Study: 25023055

Group type: EXPERIMENTAL
Intervention: Preemptive lamivudine
Number of subjects: 258

Group type: COMPARATOR
Intervention: No antiviral prophylaxis
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Patients with HBV reactivation
Number of subjects: 258
Study: 22613532

Group type: EXPERIMENTAL
Intervention: Anisodamine (0.1 - 0.2 µg × kg(‐1)× min(‐1) intravenous infusion from PCI to 24 hours after PCI)
Number of subjects: 177

Group type: COMPARATOR
Intervention: 0.9% isotonic saline (control group)
Number of subjects: 177
Study: 20220748

Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Silodosin 24 mg
Number of subjects: 186

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg (positive control)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study: 18224311

Group type: EXPERIMENTAL
Intervention: Lansoprazole (60 mg oral dose) with clarithromycin (800 mg/day)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Lansoprazole (60 mg oral dose) with fluvoxamine (50 mg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Lansoprazole (60 mg oral dose) with placebo
Number of subjects: 18
Study: 12100205

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 2 g daily
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 1 g daily (follow-up)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Glucocorticosteroids (highly dosed)
Number of subjects: 2
Study: 9589224

Group type: EXPERIMENTAL
Intervention: 20.7 mmol MgO daily for 30 days
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: 41.4 mmol MgO daily for 30 days
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 8025966

Group type: EXPERIMENTAL
Intervention: Chemoembolization using ethiodized oil (Lipiodol) and anticancer agents (Mitomycin in 40 patients, DADH in 58 patients)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Transcatheter hepatic arterial embolization (TAE) with Gelfoam or Ivalon sponge
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Chemoembolization plus TAE (repeated in 56 patients)
Number of subjects: 114
Study: 2607570

Group type: EXPERIMENTAL
Intervention: Ethambutol
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ethambutol plus INH
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: INH plus rifampicin
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 70
Study: 31914556

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (group C)
Number of subjects: 120
Study: 31362966

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS) - robot‐assisted or laparoscopic radical hysterectomy (RH)
Number of subjects: 1448

Group type: COMPARATOR
Intervention: Abdominal radical hysterectomy (RH)
Number of subjects: 1448
Study: 27861700

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 4,000 IU daily for 9 months
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 26437506

Group type: EXPERIMENTAL
Intervention: Porcelain-fused-to-metal-like crowns (PFM)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Anatomically-guided crowns (AG)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Flat design crowns (FD)
Number of subjects: 56
Study: 23571719

Group type: EXPERIMENTAL
Intervention: 12-week energy-restricted diet intervention
Number of subjects: 78
Study: 21757112

Group type: EXPERIMENTAL
Intervention: Simulator training (Sim‐T)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conventional training (Conv‐T)
Number of subjects: 14
Study: 19858396

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1,000 mg/m² with cisplatin 50 mg/m² (arm A)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1,500 mg/m² at a fixed dose rate of 10 mg/m²/min (arm B)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1,000 mg/m² with docetaxel 40 mg/m² (arm C)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1,000 mg/m² with irinotecan 100 mg/m² (arm D)
Number of subjects: 245
Study: 16997053

Group type: EXPERIMENTAL
Intervention: Serum CML level
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: History of prior cardiovascular events
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 24-hour urinary albumin-creatinine ratio
Number of subjects: 450
Study: 14970134

Group type: EXPERIMENTAL
Intervention: Remifentanil by bolus injection
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 11642083

Group type: EXPERIMENTAL
Intervention: Neoton therapy
Number of subjects: 106

Group type: COMPARATOR
Intervention: Thrombolytic therapy (TLT) without neoton
Number of subjects: 106

Group type: COMPARATOR
Intervention: Thrombolytic therapy (TLT) with streptokinase preparations
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (TLT) with streptokinase preparations and neoton
Number of subjects: 106
Study: 9407640

Group type: EXPERIMENTAL
Intervention: New mononuclear cell collection program
Number of subjects: 7

Group type: COMPARATOR
Intervention: PBSC‐LYM program
Number of subjects: 7
Study: 8220968

Group type: EXPERIMENTAL
Intervention: 0.1 mmol per kilogram body weight (kgbw)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 0.3 mmol per kilogram body weight (kgbw)
Number of subjects: 28
Study: 3324137

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31539436

Group type: EXPERIMENTAL
Intervention: Laryngeal Handshake Method (LHM)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Traditional Method (TM)
Number of subjects: 32
Study: 28112467

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 3230

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI) with drug-eluting stents (DES)
Number of subjects: 3230
Study: 24602091

Group type: EXPERIMENTAL
Intervention: Exercise + Caloric Restriction (CR: 3.2 kcal/kg body weight per day, 8-h walking + 45-min arm cranking per day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control diet + reduced exercise
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Post WCR (4 weeks)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Post WCR (1 year)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: WCR
Number of subjects: 15

Group type: COMPARATOR
Intervention: DIET
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: POST1
Number of subjects: 15
Study: 22798152

Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy (CIMT)
Number of subjects: 10
Study: 21531706

Group type: EXPERIMENTAL
Intervention: Immediate treatment after first seizure
Number of subjects: 419

Group type: COMPARATOR
Intervention: Treatment only in the event of seizure recurrence
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Both groups (treated and untreated)
Number of subjects: 419